Insulin aspart, recombinant Subcutaneous and Letrozole and ribociclib
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Letrozole and ribociclib and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Leucovorin
- Insulin aspart, recombinant Subcutaneous-Leucovorin Calcium
- Insulin aspart, recombinant Subcutaneous-Leucovorin injection
- Insulin aspart, recombinant Subcutaneous-Leucovorin Oral, Intravenous, Injection
- Insulin aspart, recombinant Subcutaneous-Leucovorin Tablets
- Insulin aspart, recombinant Subcutaneous-Leukeran
- Letrozole and ribociclib-Insulin degludec
- Letrozole and ribociclib-Insulin Degludec (U-100) Prefilled Pens
- Letrozole and ribociclib-Insulin Degludec (U-100) Vials
- Letrozole and ribociclib-Insulin Degludec (U-200) Prefilled Pens
- Letrozole and ribociclib-Insulin degludec and liraglutide
- Letrozole and ribociclib-Insulin degludec and liraglutide Subcutaneous